🇺🇸 FDA
Pipeline program

ABI-H2158

ABI-H2158-103

Phase 2 small_molecule completed

Quick answer

ABI-H2158 for Chronic Hepatitis B is a Phase 2 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 3 ClinicalTrials.gov record(s).

Program details

Company
ASSEMBLY BIOSCIENCES, INC.
Indication
Chronic Hepatitis B
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials